158 related articles for article (PubMed ID: 11446738)
1. Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia.
Vaisban E; Zaina A; Braester A; Manaster J; Horn Y
Ann Hematol; 2001 May; 80(5):314-5. PubMed ID: 11446738
[TBL] [Abstract][Full Text] [Related]
2. Acute tumour lysis syndrome following a single-dose corticosteroid in children with acute lymphoblastic leukaemia.
Duzova A; Cetin M; Gümrük F; Yetgin S
Eur J Haematol; 2001 Jun; 66(6):404-7. PubMed ID: 11488940
[TBL] [Abstract][Full Text] [Related]
3. Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma.
Sparano J; Ramirez M; Wiernik PH
Cancer; 1990 Mar; 65(5):1072-3. PubMed ID: 2302658
[TBL] [Abstract][Full Text] [Related]
4. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Yang H; Rosove MH; Figlin RA
Am J Hematol; 1999 Dec; 62(4):247-50. PubMed ID: 10589082
[TBL] [Abstract][Full Text] [Related]
5. Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
Calvo-Villas JM; Urcuyo BM; Umpierrez AM; Sicilia F
Onkologie; 2008 Apr; 31(4):197-9. PubMed ID: 18418022
[TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
7. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
[TBL] [Abstract][Full Text] [Related]
8. Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
Ramachandran A; Majumdar G
Hematol J; 2004; 5(6):528-9. PubMed ID: 15570297
[TBL] [Abstract][Full Text] [Related]
9. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
Cheson BD; Frame JN; Vena D; Quashu N; Sorensen JM
J Clin Oncol; 1998 Jul; 16(7):2313-20. PubMed ID: 9667245
[TBL] [Abstract][Full Text] [Related]
10. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
Cheson BD
Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
[TBL] [Abstract][Full Text] [Related]
11. Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab).
Jensen M; Winkler U; Manzke O; Diehl V; Engert A
Ann Hematol; 1998; 77(1-2):89-91. PubMed ID: 9760161
[TBL] [Abstract][Full Text] [Related]
12. Tumor lysis syndrome and metastatic melanoma.
Meeks MW; Hammami MB; Robbins KJ; Cheng KL; Lionberger JM
Med Oncol; 2016 Dec; 33(12):134. PubMed ID: 27807723
[TBL] [Abstract][Full Text] [Related]
13. Acute tumor lysis syndrome complicating conditioning therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia.
Nomdedéu J; Martino R; Sureda A; Huidobro G; López R; Brunet S; Domingo-Albós A
Bone Marrow Transplant; 1994 May; 13(5):659-60. PubMed ID: 8054919
[TBL] [Abstract][Full Text] [Related]
14. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
Montalban C; Liaño F; Aguilera A
Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
[TBL] [Abstract][Full Text] [Related]
15. Tumor lysis syndrome following single-dose mitoxantrone.
Benekli M; Savaş MC; Güllü IH; Kadayifçi A; Akpek G; Kars A; Güler N; Kansu E; Tekuzman G; Firat D
Chemotherapy; 1995; 41(6):470-2. PubMed ID: 8529438
[TBL] [Abstract][Full Text] [Related]
16. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
17. Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
Moutouh-de Parseval LA; Weiss L; DeLap RJ; Knight RD; Zeldis JB
J Clin Oncol; 2007 Nov; 25(31):5047. PubMed ID: 17971612
[No Abstract] [Full Text] [Related]
18. Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide.
McCroskey RD; Mosher DF; Spencer CD; Prendergast E; Longo WL
Cancer; 1990 Jul; 66(2):246-50. PubMed ID: 2369709
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
Frame JN; Dahut WL; Crowley S
N Engl J Med; 1992 Nov; 327(19):1396-7. PubMed ID: 1406856
[No Abstract] [Full Text] [Related]
20. Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids.
Coutinho AK; de O Santos M; Pinczowski H; Feher O; del Giglio A
Am J Hematol; 1997 Jan; 54(1):85-6. PubMed ID: 8980269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
